1897-4287

Hereditary Cancer in Clinical Practice

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 718 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact718 DOIs
2

Add abstracts to 568 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact568 DOIs
3

Deposit reference lists for 334 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact334 DOIs

DOIs for this ISSN

Showing the top 5 of 835 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A short guide to hereditary diffuse gastric cancer (10.1186/1897-4287-5-4-183)
Abstract References ORCID License
160.21 39
2 The updated Swedish family-cancer database used to assess fa… (10.1186/1897-4287-4-4-186)
Abstract References ORCID License
150.51 31
3 Colorectal Cancer in the Family: Psychosocial Distress and S… (10.1186/1897-4287-5-2-59)
Abstract References ORCID License
146.24 28
4 Base excision repair and the role of MUTYH (10.1186/1897-4287-5-4-199)
Abstract References ORCID License
144.72 27
5 The genetic basis of colonic adenomatous polyposis syndromes (10.1186/s13053-017-0065-x)
Abstract ORCID License
141.91 77
6 Familial paragangliomas (10.1186/1897-4287-4-4-169)
Abstract References ORCID License
136.17 22
7 Establishing a Cancer Genetics Programme in Asia - the Singa… (10.1186/1897-4287-4-3-126)
Abstract References ORCID License
132.22 20
8 Thyroid cancer in a patient with a germline MSH2 mutation. C… (10.1186/1897-4287-6-1-15)
Abstract References ORCID License
132.22 20
9 Colorectal cancer incidence in path_MLH1 carriers subjected… (10.1186/s13053-017-0078-5)
Abstract ORCID License
126.76 48
10 Childhood Adrenocortical Tumours: a Review (10.1186/1897-4287-4-2-81)
Abstract References ORCID License
120.41 15
11 Gene Expression Profiling in Hereditary, BRCA1-linked Breast… (10.1186/1897-4287-4-1-28)
Abstract References ORCID License
117.61 14
12 Gene Expression Profiling in Familial Adenomatous Polyposis… (10.1186/1897-4287-5-2-79)
Abstract References ORCID License
117.61 14
13 Neoadjuvant therapy with cisplatin in BRCA1-positive breast… (10.1186/1897-4287-9-s2-a4)
Abstract References ORCID License
114.61 13
14 BRCA1 and BRCA2 mutation spectrum – an update on mutation di… (10.1186/s13053-017-0085-6)
Abstract ORCID License
112.89 31
15 Hereditary pancreatic cancer: related syndromes and clinical… (10.1186/s13053-017-0069-6)
Abstract ORCID License
111.85 30
16 Cisplatin in breast cancer treatment in BRCA1 carriers (10.1186/1897-4287-10-s4-a17)
Abstract References ORCID License
111.39 12
17 BRCA1 4153delA founder mutation in Russian ovarian cancer pa… (10.1186/1897-4287-4-4-193)
Abstract References ORCID License
111.39 12
18 A hypothesis-generating search for new genetic breast cancer… (10.1186/1897-4287-5-1-17)
Abstract References ORCID License
111.39 12
19 Hereditary breast and ovarian cancer (10.1186/1897-4287-6-2-88)
Abstract References ORCID License
111.39 12
20 Recurrent mutations of BRCA1, BRCA2 and PALB2 in the populat… (10.1186/s13053-016-0046-5)
Abstract ORCID License
110.78 29
21 Central nervous system gadolinium accumulation in patients u… (10.1186/s13053-017-0084-7)
Abstract ORCID License
109.68 28
22 Cancer and Lhermitte-Duclos disease are common in Cowden syn… (10.1186/1897-4287-8-6)
Abstract ORCID
108.80 149
23 Germline PTEN mutations are rare and highly penetrant (10.1186/1897-4287-4-4-177)
Abstract References ORCID License
107.92 11
24 Motivators and barriers of tamoxifen use as risk-reducing me… (10.1186/s13053-017-0075-8)
Abstract ORCID License
104.85 24
25 Epimutations, Inheritance and Causes of Aberrant DNA Methyla… (10.1186/1897-4287-4-2-75)
Abstract References ORCID License
104.14 10
26 Selenium and the risk of cancer in BRCA1 carriers (10.1186/1897-4287-9-s2-a5)
Abstract References ORCID License
104.14 10
27 Germline deletions in the EPCAM gene as a cause of Lynch syn… (10.1186/1897-4287-11-9)
Abstract ORCID
103.96 119
28 Emotional impact on the results of BRCA1 and BRCA2 genetic t… (10.1186/s13053-017-0077-6)
Abstract ORCID License
103.52 23
29 The role of BRCA1 and BRCA2 mutations in prostate, pancreati… (10.1186/s13053-015-0038-x)
Abstract ORCID
102.65 112
30 The Association of the COMT V158M Polymorphism with Endometr… (10.1186/1897-4287-4-2-94)
Abstract References ORCID License
100.00 9
31 Clinical and genetic characterization of hereditary breast c… (10.1186/s13053-017-0079-4)
Abstract ORCID License
95.91 18
32 Familial Multiple Myeloma: Report on Two Families and Discus… (10.1186/1897-4287-5-2-72)
Abstract References ORCID License
95.42 8
33 Recurrent APC gene mutations in Polish FAP families (10.1186/1897-4287-5-4-195)
Abstract References ORCID License
95.42 8
34 Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; differ… (10.1186/1897-4287-7-17)
Abstract ORCID
93.17 72
35 Frequency of BRCA1 and BRCA2 causative founder variants in o… (10.1186/s13053-018-0089-x)
Abstract ORCID License
92.28 16
36 Multiple Osteochondromas: Clinicopathological and Genetic Sp… (10.1186/1897-4287-2-4-161)
Abstract ORCID
91.63 67
37 An incidental finding of a large genomic deletion of BRCA1 o… (10.1186/1897-4287-10-s2-a73)
Abstract References ORCID License
90.31 7
38 Arsenic (As) and breast cancer risk (10.1186/1897-4287-10-s4-a8)
Abstract References ORCID License
90.31 7
39 Factors Influencing Cancer Risk Perception in High Risk Popu… (10.1186/1897-4287-9-2)
Abstract ORCID
90.31 63
40 Screening with magnetic resonance imaging, mammography and u… (10.1186/s13053-017-0064-y)
Abstract ORCID License
90.31 15
41 Intensive breast screening in BRCA2 mutation carriers is ass… (10.1186/s13053-016-0048-3)
Abstract ORCID
89.97 62
42 Hereditary and non-hereditary branches of family eligible fo… (10.1186/s13053-017-0067-8)
Abstract ORCID License
88.21 14
43 The potential role of miRNAs in therapy of breast and ovaria… (10.1186/s13053-017-0076-7)
Abstract ORCID License
85.96 13
44 CDKN2A founder mutation in pancreatic ductal adenocarcinoma… (10.1186/s13053-018-0088-y)
Abstract ORCID License
85.96 13
45 Prevalence and predictors of germline CDKN2A mutations for m… (10.1186/1897-4287-12-20)
Abstract ORCID
85.80 51
46 Zinc and breast cancer risk (10.1186/1897-4287-10-s4-a6)
Abstract References ORCID License
84.51 6
47 MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Co… (10.1186/1897-4287-4-2-90)
Abstract References ORCID License
84.51 6
48 Selected aspects of inherited susceptibility to prostate can… (10.1186/1897-4287-5-3-164)
Abstract References ORCID License
84.51 6
49 Lynch syndrome (HNPCC) (10.1186/1897-4287-6-2-99)
Abstract References ORCID License
84.51 6
50 Cytotoxic and targeted therapy for hereditary cancers (10.1186/s13053-016-0057-2)
Abstract ORCID
81.16 41